Clinical

trials

Clinical trials offer patients the opportunity to become involved in treatments that may well become tomorrow’s standard of care. 

Find Clinical Trials

New tests and treatments aren’t offered to the public as soon as they’re made. They need to be studied. Clinical trials study how safe and helpful tests and treatments are. When found to be safe and helpful, they may become tomorrow’s standard of care. Clinical trials can study many things, such as:

  • New drugs not yet approved by the Australia Government or U.S. FDA (Food and Drug Administration)
  • New uses of drugs already approved by the Australia Government or FDA
  • New ways to give drugs, such as in pill form
  • Use of alternative medicines, such as herbs and vitamins
  • New tests to find and track disease
  • Drugs or procedures that relieve symptoms

Submit a Clinical Trial

If your company/institution would like to submit a clinical trial to be included on our website, please contact steve@CholangiocarcinomaAustralia.org for more information.

If you would like to post your clinical trial on our clinical trial page and to be shared on social media. Please make sure to use patient-friendly language. Contact steve@CholangiocarcinomaAustralia.org for more information.

It is not the intention of the Cholangiocarcinoma Foundation to provide specific medical advice.  We provide website users with information to help them better understand their health conditions and the current approaches related to prevention, diagnosis, treatment and supportive care. You are urged to always seek the advice of your physician or other qualified healthcare provider.

Learn more about clinical trials

Please note that the clinical trials mentioned are not the only clinical trials available for cholangiocarcinoma patients, the following clinical trials were submitted by the organizations conducting the trial.  Please visit Australian Cancer Trials or for a global reference visit clinicaltrials.gov for a more comprehensive list.

If your company/institution would like to submit a clinical trial to be included on our website, please contact steve@CholangiocarcinomaAustralia.org for more information.

If you would like to post your clinical trial on our clinical trial page and to be shared on social media. Please make sure to use patient-friendly language. Contact steve@CholangiocarcinomaAustralia.org for more information.

Clinical Trial Search

Australian Search

Australian Cancer Trials; australiancancertrials.gov.au/

USA Search 

ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.

CCF Search

This is the first treatment given for the disease.

Click here to see the current trials list by our CCF partner in the USA

These are trials that may be available after you have ceased or discontinuation your of first-line of therapy.

Click here to see the current trials list by our CCF partner in the USA

Chemotherapy is a chemical substance, or cytotoxic, there are many different types of chemotherapies and they are often used in combination with other chemotherapy agents or immunotherapies.

Click here to see the current trials list by our CCF partner in the USA

Trials with drugs designed to target specific genes or proteins.

Click here to see the current trials list by our CCF partner in the USA

Trials that treat disease with substances that stimulate or intervene with the immune response.

Click here to see the current trials list by our CCF partner in the USA

Therapies that use high-energy radiation to shrink tumours and kill cancer.

Click here to see the current trials list by our CCF partner in the USA

Therapies that are new or are considered an unusual approach to treating a patient or disease.

Click here to see the current trials list by our CCF partner in the USA

A complete list of all of the clinical trials submitted to the Cholangiocarcinoma Foundation. CCF Australia works closely with our CCF partner in the USA, it is good practice to be globally aware of clinical trial opportunities, many will also be or become available in Australia.

Click here to view a list of CCF (USA) submitted clinical trials

Please visit our Biomarkers Matter page to learn more about how your biopsy can reveal which type of clinical trial is best for you

Questions -Answers – Links

It is not the intention of the Cholangiocarcinoma Foundation to provide specific medical advice.  We provide website users with information to help them better understand their health conditions and the current approaches related to prevention, diagnosis, treatment and supportive care. You are urged to always seek the advice of your physician or other qualified healthcare provider.

Learn more about clinical trials

Please note that the clinical trials mentioned are not the only clinical trials available for cholangiocarcinoma patients, the following clinical trials were submitted by the organizations conducting the trial.  Please visit Australian Cancer Trials or for a global reference visit clinicaltrials.gov for a more comprehensive list.

Many new tests and treatments are constantly in development, but many are not yet available to the public or not offered as a “First-line” treatment option. These new tests and treatments are often offered to patients within a strictly controlled clinical trial study.

Clinical trials offer patients the opportunity to become involved in treatments that may well become tomorrow’s standard of care. It is important that your Oncologists are conversant/aware of current trial options.

For Cholangiocarcinoma patients in Australia, there are limited Clinical Trial options, but that should not dissuade you from researching all possibilities.

Clinical trials will require that you have the biomarkers that align to specific trial requirements hence the importance of obtaining a biopsy (tissue sample of the tumour) and having it tested, in the first instance a simple IHC test (3-5days) and inexpensive and thereafter a full molecular (Genomic) profile.

For Cholangiocarcinoma patients it would be a significant mistake to assume that your surgeon or Oncologist will automatically engage an IHC (Staining test) on your behalf. You will need to ensure or ask that this be completed, in particular, have them highlight PD-L1, MSi Results – HER2 should also be included.